EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics

Szymon J Krawczyk, Marta Leśniczak-Staszak, Ewelina Gowin iD, Witold Szaflarski

Biomolecules · 07.10.2024 · 14 (10) · 1263

DOI: 10.3390/biom14101263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.10.2024. Verfasst von Szymon J Krawczyk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznań, Poland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ribosomes. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre in Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics targeting the bacterial ribosome are essential to combating bacterial infections. These antibiotics bind to various sites on the ribosome, inhibiting different stages of protein synthesis. This review provides a comprehensive overview of the mechanisms of action of clinically relevant antibiotics that target the bacterial ribosome, including macrolides, lincosamides, oxazolidinones, aminoglycosides, tetracyclines, and chloramphenicol. The structural and functional details of antibiotic interactions with ribosomal RNA, including specific binding sites, interactions with rRNA nucleotides, and their effects on translation processes, are discussed. Focus is placed on the diversity of these mechanisms and their clinical implications in treating bacterial infections, particularly in the context of emerging resistance. Understanding these mechanisms is crucial for developing novel therapeutic agents capable of overcoming bacterial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsRibosomesHumansRNA, RibosomalBacteriaBacterial InfectionsBinding SitesProtein BiosynthesisDrug Resistance, Bacterial

Stichwörter der Autor:innen

antibioticsprotein biosynthesisribosome

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal

Autor:innen und Institutionen

  • Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznań, Poland.
  • Department of Health Promotion, Poznan University of Medical Sciences, 60-781 Poznań, Poland.
  • Department of Immunology, Poznan University of Medical Sciences, 60-806 Poznań, Poland.

ORCID-Profile: Ewelina Gowin

Förderung

  • National Science Centre in Poland

Zitieren

APA

Krawczyk, S. J., Leśniczak-Staszak, M., Gowin, E., & Szaflarski, W. (2024). Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. Biomolecules, 14(10), 1263. https://doi.org/10.3390/biom14101263

Vancouver

Krawczyk SJ, Leśniczak-Staszak M, Gowin E, Szaflarski W. Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. Biomolecules. 2024;14(10):1263. doi:10.3390/biom14101263

BibTeX
@article{Krawczyk2024,
  author = {Krawczyk, Szymon J and Leśniczak-Staszak, Marta and Gowin, Ewelina and Szaflarski, Witold},
  title = {Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {10},
  pages = {1263},
  doi = {10.3390/biom14101263}
}
Kostenlos starten →